Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Tofacitinib significantly improved hair loss and lesions in a patient with overlapping autoimmune disorders.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

Eculizumab helps reduce blood transfusions and stabilize hemoglobin but increases infection risk and is expensive.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

Ixekizumab may be an effective first treatment for a rare skin condition causing hair loss.

Switching from adalimumab to ixekizumab improved a patient's psoriasis and reversed hair whitening.

Sintilimab treatment caused hair loss but led to complete tumor remission.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

Co-trimoxazole may help treat autoimmune diseases.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

Lung cancer patients on immunotherapy and chemotherapy often experience severe fatigue, drowsiness, and appetite loss.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

A medicine called tofacitinib worked to treat a hair loss condition linked with a muscle and skin disease.

A protein called lfTSLP is important in causing allergic and other skin diseases and could be a target for treatment.

Efalizumab can cause unexpected excessive hair growth.

Tofacitinib helped regrow hair in a lupus patient with alopecia.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Ixekizumab effectively treats generalized pustular psoriasis.

Patients with acute and subacute skin lupus respond faster to belimumab than those with chronic skin lupus.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

An antibiotic called co-trimoxazole can effectively treat autoimmune diseases.

Infliximab can trigger lupus-like symptoms in Crohn's disease patients.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.

Tralokinumab effectively improved atopic dermatitis symptoms in most patients, but some stopped due to side effects like hair loss.